PBH stock forecast
Our latest prediction for Prestige Consumer Healthcare, Inc.'s stock price was made on the Feb. 5, 2018 when the stock price was at 35.53$.
In the short term (2weeks), PBH's stock price should outperform the market by 2.54%. During that period the price should oscillate between -5.28% and +9.03%.
In the medium term (3months), PBH's stock price should outperform the market by 1.21%. During that period the price should oscillate between -12.54% and +18.07%.Get email alerts
About Prestige Consumer Healthcare, Inc.
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.
At the moment the company generates 1020M USD in revenues.
On its last earning announcement, the company reported a profit of 6.38$ per share.
The book value per share is 22.46$
Three months stock forecastFeb. 5, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|